Tectonic Therapeutic reported $17K in Interest Expense on Debt for its fiscal quarter ending in June of 2025.




Interest Expense On Debt Change Date
Alnylam Pharmaceuticals USD 40.25M 1.6M Jun/2025
Celltrion KRW 17.04B 1.34B Mar/2025
Cspc Pharmaceutical CNY 10.38M 934K Dec/2024
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd 30M 20M Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
Ionis Pharmaceuticals USD 19M 0 Jun/2025
Kangmei Pharma CNY 1.67M 1.45M Mar/2025
Knight Therapeutics CAD 1.91M 369K Sep/2024
Laboratorios Farma EUR 699K 666.2K Jun/2025
MacroGenics USD 802K 826K Jun/2025
Medical Developments International AUD 21K 23K Jun/2024
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Pfizer USD 654M 0 Jun/2025
Qiagen NV USD 7.6M 311K Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi EUR 148M 65M Jun/2025
Sarepta Therapeutics USD 5.23M 725K Jun/2025
Sartorius EUR 41.4M 51.4M Jun/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Takeda JPY 107.16B 56.83B Jun/2025
Tilray USD 7.77M 2.08M Nov/2024
Zz Pientze Pharmaceu 46.05M 36.5M Jun/2025